Nuvectra Corp (NASDAQ:NVTR) saw unusually-strong trading volume on Friday . Approximately 6,499,562 shares changed hands during trading, an increase of 1,451% from the previous session’s volume of 419,139 shares.The stock last traded at $1.79 and had previously closed at $1.49.
A number of research analysts have weighed in on NVTR shares. ValuEngine raised Nuvectra from a “hold” rating to a “buy” rating in a report on Thursday, October 10th. Zacks Investment Research downgraded Nuvectra from a “buy” rating to a “hold” rating in a research report on Wednesday. Piper Jaffray Companies dropped their price target on Nuvectra from $18.00 to $4.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Finally, JMP Securities dropped their price target on Nuvectra to $10.00 and set an “outperform” rating for the company in a research report on Thursday, August 1st. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. Nuvectra has an average rating of “Buy” and a consensus target price of $8.38.
The stock has a market cap of $32.01 million, a P/E ratio of -0.56 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a quick ratio of 4.42 and a current ratio of 4.86. The stock has a 50-day moving average price of $1.57 and a 200-day moving average price of $3.89.
Institutional investors and hedge funds have recently modified their holdings of the company. Acadian Asset Management LLC bought a new stake in shares of Nuvectra during the 2nd quarter valued at about $35,000. SNS Financial Group LLC bought a new stake in Nuvectra in the 2nd quarter worth approximately $36,000. Resources Investment Advisors LLC. bought a new stake in Nuvectra in the 2nd quarter worth approximately $39,000. Tower Research Capital LLC TRC lifted its position in Nuvectra by 1,431.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 13,030 shares of the company’s stock worth $44,000 after buying an additional 12,179 shares during the last quarter. Finally, Jefferies Group LLC bought a new stake in Nuvectra in the 2nd quarter worth approximately $52,000. Hedge funds and other institutional investors own 78.10% of the company’s stock.
Nuvectra Company Profile (NASDAQ:NVTR)
Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs.
Recommended Story: When is a capital gain realized?
Receive News & Ratings for Nuvectra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra and related companies with MarketBeat.com's FREE daily email newsletter.